Teresa Whalen, RPh

Teresa Whalen, RPh has a diverse work experience in the healthcare industry. Teresa is currently the CEO of CytoAgents, a clinical stage drug development company focused on treating Cytokine Release Syndrome (CRS). Prior to that, they served as a Member of the Board of Directors at St. Clair Hospital. Teresa is also a Member and Investment Committee Co-Chair at Next Act Fund LLC, where they are responsible for evaluating prospective entrepreneurs and leading due diligence teams. Teresa is a Life Sciences Investor at BlueTree Venture Fund, providing funding and guidance to startup companies. Previously, they were the CEO of ExcellenceRx, where they developed a temperature tracking logistic solution for Specialty Pharmacies. Teresa also held strategic partnership and senior management roles at NTT DATA Global Solutions Corporation, UPMC, McKesson, and Baxter International Inc. Teresa started their career at Siemens Healthcare as a Zone Sales Manager, overseeing the sales team for the Northeast region of the U.S.

Teresa Whalen, RPh obtained a Bachelor of Science (B.S.) degree in Pharmacy from the University of Pittsburgh, completing their education from 1986 to 1991. Additionally, they hold the certification of Registered Pharmacist (RPh), although specific details such as the institution and date of certification are not provided.